For transplant programs, SRTR will stop all patient follow-up on March 12, 2020, the day prior to the public health emergency declaration, i.e., waitlist survival, transplant rate, and outcomes will not be assessed after that date.
The Health Resources and Services Administration (HRSA) Division of Transplantation thanked ASTS and its members for supporting the Workplace Partnership for Life (WPFL) Hospital Campaign in the nine years since its launch and for contributing to its continued success in 2020.
To disseminate the latest science in transplantation surgery while safeguarding the health and safety of attendees, we have decided to hold the 21st Annual State of the Art Winter Symposium virtually.
In light of the events in recent months that have illuminated the plight of Black Americans, I continue to reflect on the role we must play in confronting racism and the devastating consequences of this persistent evil.
Racism is morally wrong, inhuman, and unjust. In recent times we have all witnessed and lived through events that continue to illustrate that racism is an integral part of our society.
On June 26, 2020, the Centers for Disease Control (CDC) released a report entitled, “Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection — U.S. Public Health Service Guideline, 2020”.
It is with great sorrow that the American Society of Transplant Surgeons (ASTS) announces one of our own, Dr. Felicitas Koller and her husband, lost their 4-year-old son Tunis on Sunday in a tragic accident at home.
C-Path's Transplant Therapeutics Consortium (TTC), ASTS, and the American Society of Transplantation (AST) are pleased to announce the first-ever recipients of the TTC Data Trailblazer Award.
The ASTS Diversity Issues Committee is accepting applications for a funded opportunity to become a Health Disparities Research Education Program (HDREP) Scholar.
Critical Path Institute (C-Path) announced today that its Transplant Therapeutics Consortium (TTC) has received a positive response to its Letter of Intent (LOI) from the U.S. Food and Drug Administration (FDA) detailing the decision to accept the Composite Biomarker Panel (iBox Scoring System) into the Center for Drug Evaluation and Research (CDER) Biomarker Qualification Program (BQP).